Tandem Diabetes Care TNDM Convertible Debt (Non-Current)
Convertible Debt (Non-Current) at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:ConvertibleDebtNoncurrent.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's convertible debt (non-current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's convertible debt (non-current)?
- Tandem Diabetes Care (TNDM) reported convertible debt (non-current) of $601.77M in Q1 2026.
- How has Tandem Diabetes Care's convertible debt (non-current) changed year-over-year?
- Tandem Diabetes Care's convertible debt (non-current) increased by 94.9% year-over-year, from $308.71M to $601.77M.
- What is the long-term trend for Tandem Diabetes Care's convertible debt (non-current)?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's convertible debt (non-current) has grown at a 8.8% compound annual growth rate (CAGR), from $202.98M to $310.04M.
- What does convertible debt (non-current) mean?
- This represents the portion of long-term debt obligations that can be converted into equity shares at the option of the holder, maturing beyond the next twelve months. It serves as a critical indicator of a company's long-term leverage and potential future dilution for existing shareholders. Investors monitor this to assess the firm's capital structure flexibility and the potential impact of conversion features on future earnings per share.